# Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)

> **NCT04340895** · NA · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 250 (actual)

## Conditions studied

- Mild-to-moderate Ulcerative Colitis

## Interventions

- **OTHER:** Faecal Calprotectin Home Test
- **OTHER:** PRO-2 Scoring

## Key facts

- **NCT ID:** NCT04340895
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-14
- **Primary completion:** 2023-10-20
- **Final completion:** 2023-10-20
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04340895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04340895, "Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04340895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*